Literature DB >> 19706994

"Hypothesis of seven balances": molecular mechanisms behind alcoholic liver diseases and association with PPARalpha.

Takashi Moriya1, Hisao Naito, Yuki Ito, Tamie Nakajima.   

Abstract

OBJECTIVES: The purpose of this review to collate current leading scientific advances of molecular mechanisms in alcoholic liver diseases and to propose a working "hypothesis of seven balances" in relation to peroxisome proliferator activated receptor alpha (PPARalpha), which has important roles in fatty acid oxidation, oxidative stress, inflammatory responses, and possibly liver fibrosis.
METHODS: We conducted an extensive literature review of over a hundred publications and collated the findings with evidence generated in our laboratory.
RESULTS: Our research points to a working hypothesis of seven balances for alcoholic liver diseases consisting of: 1) ethanol oxidation balance in hepatocytes; 2) PPAR alpha activities in liver; 3) fatty acid metabolism balance in hepatic mitochondria; 4) gastrointestinal response to ethanol, acetaldehyde and lipopolysaccharide (LPS); 5) Kupffer cells response to LPS, oxidative stress and inflammatory cytokines; 6) adiponectin levels in plasma interchangeably regulated by tumor necrosis factor-alpha (TNF-alpha); and 7) stellate cells response to all of the above promoting hepatic fibrosis. Cellular mechanisms behind alcoholic liver diseases reveal close temporal associations of PPARalpha, adiponectin, TNF-alpha, cellular inflammation, proliferation, and potentially fibrosis as illustrated in "the hypothesis of seven balances."
CONCLUSIONS: The regulation and adjustment of PPARalpha activation underlying the balance of molecular cascades might resolve the progression of alcoholic liver diseases by reducing oxidative stress and inflammatory effects induced by nuclear factor-kappaB as well as the associated adiponectin pathway. Further elucidation of these pathways would reveal exciting new prospects for treating alcoholic liver diseases and other related liver disorders.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706994     DOI: 10.1539/joh.k9001

Source DB:  PubMed          Journal:  J Occup Health        ISSN: 1341-9145            Impact factor:   2.708


  15 in total

Review 1.  The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver.

Authors:  Robin D Clugston; Madeleine A Gao; William S Blaner
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

2.  Schisandra chinensis prevents alcohol-induced fatty liver disease in rats.

Authors:  Hyoung Joon Park; Soo-Jung Lee; Yuno Song; Sun-Hee Jang; Yeoung-Gyu Ko; Suk Nam Kang; Byung Yeoup Chung; Hong-Duck Kim; Gon-Sup Kim; Jae-Hyeon Cho
Journal:  J Med Food       Date:  2014-01       Impact factor: 2.786

3.  Lipidomic changes in rat liver after long-term exposure to ethanol.

Authors:  Harshica Fernando; Kamlesh K Bhopale; Shakuntala Kondraganti; Bhupendra S Kaphalia; G A Shakeel Ansari
Journal:  Toxicol Appl Pharmacol       Date:  2011-06-26       Impact factor: 4.219

Review 4.  Mitochondrial dysfunction in nonalcoholic fatty liver disease and alcohol related liver disease.

Authors:  Pankaj Prasun; Ilona Ginevic; Kimihiko Oishi
Journal:  Transl Gastroenterol Hepatol       Date:  2021-01-05

5.  Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study.

Authors:  Robin D Clugston; Hongfeng Jiang; Man Xia Lee; Roseann Piantedosi; Jason J Yuen; Rajasekhar Ramakrishnan; Michael J Lewis; Max E Gottesman; Li-Shin Huang; Ira J Goldberg; Paul D Berk; William S Blaner
Journal:  J Lipid Res       Date:  2011-08-19       Impact factor: 5.922

6.  Development of novel rat model for high-fat and high-cholesterol diet-induced steatohepatitis and severe fibrosis progression in SHRSP5/Dmcr.

Authors:  Kazuya Kitamori; Hisao Naito; Hazuki Tamada; Miya Kobayashi; Daisuke Miyazawa; Yuko Yasui; Kunihiro Sonoda; Satoru Tsuchikura; Naomi Yasui; Katsumi Ikeda; Takashi Moriya; Yukio Yamori; Tamie Nakajima
Journal:  Environ Health Prev Med       Date:  2011-08-19       Impact factor: 3.674

7.  Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.

Authors:  Takayuki Koga; Pei-Li Yao; Maryam Goudarzi; Iain A Murray; Gayathri Balandaram; Frank J Gonzalez; Gary H Perdew; Albert J Fornace; Jeffrey M Peters
Journal:  J Biol Chem       Date:  2016-10-20       Impact factor: 5.157

8.  Pharmacological ceramide reduction alleviates alcohol-induced steatosis and hepatomegaly in adiponectin knockout mice.

Authors:  Jason M Correnti; Egle Juskeviciute; Aditi Swarup; Jan B Hoek
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

9.  Ginsenosides from stems and leaves of ginseng prevent ethanol-induced lipid accumulation in human L02 hepatocytes.

Authors:  Chao-Feng Hu; Li-Ping Sun; Qin-He Yang; Da-Xiang Lu; Sen Luo
Journal:  Chin J Integr Med       Date:  2016-09-10       Impact factor: 1.978

Review 10.  Peroxisome proliferator-activated receptor α, a potential therapeutic target for alcoholic liver disease.

Authors:  Yue-Min Nan; Rong-Qi Wang; Na Fu
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.